AID |
activation-induced deaminase |
AIDS |
acute immunodeficiency syndrome |
AITL |
angioimmunoblastic T cell lymphoma |
AP-1 |
activator protein 1 |
ATM |
ataxia telangiectasia mutated |
BALF |
BamHI-A fragment leftward open reading frame |
BARF |
BamHI-A fragment rightward open reading frame |
BART |
BamHI-A fragment rightward transcript |
BGLF |
BamHI-G fragment leftward open reading frame |
BHRF |
BamHI-H fragment rightward open reading frame |
BILF |
BamHI-I fragment leftward open reading frame |
BL |
Burkitt’s lymphoma |
BLLF |
BamHI-L fragment leftward open reading frame |
BMRF |
BamHI-M fragment rightward open reading frame |
BNLF |
BamHI-N fragment leftward open reading frame |
bZIP |
basic leucine zipper |
BRLF |
BamHI-R fragment leftward open reading frame |
BZLF |
BamH1-Z fragment leftward open reading frame |
CNS |
central nervous system |
CPB |
CREB binding protein |
CPD |
cell penetration domain |
CR |
complement receptors |
DBD |
DNA binding domain of ZEBRA |
DD |
dimerization domain of ZEBRA |
DLBCL |
diffuse large B cell lymphoma |
EBER |
EBV-encoded small RNA |
eBL |
endemic Burkitt’s lymphoma |
EBNA |
EBV nuclear antigen |
EBV |
Epstein-Barr Virus |
ECS |
Elongin B/C-Cul2/5-SOCS-box protein |
GC |
germinal center |
GI |
genome instability |
HDAC |
histone deacetylases |
hIL |
human interleukin |
HIV |
human immunodeficiency virus |
HL |
Hodgkin lymphoma |
HLA |
human leukocyte antigen |
IARC |
international agency for research on cancer |
IE |
immediate early |
IFN |
interferon |
IGH |
immunoglobulin heavy chain |
IL |
interleukin |
LCL |
lymphoblastoid cell lines |
LMP |
latent membrane protein |
MHC |
major histocompatibility complex |
MMP |
matrix metalloproteinase |
MYC |
myelocytoma |
NF-κB |
nuclear factor kappa B |
NFAT |
nuclear factor activated T cells |
NHL |
non-hodgkin lymphoma |
NK |
natural killers |
NLS |
nuclear localization sequence |
NOS |
DLBCL not otherwise specified |
NPC |
nasopharyngeal carcinoma |
PAL |
pyothorax associated lymphoma |
PBL |
peripheral blood lymphocytes |
PEL |
primary effusion lymphoma |
PTLD |
post-transplant lymphoproliferative disorders |
ROS |
reactive oxygen species |
SCID |
severe combined immunodeficiency |
SUMO-1 |
small ubiquitin-related modifier 1 |
TAD |
transactivation domain of ZEBRA |
TAP |
transporter associated with antigen processing |
TGF-β |
tumor growth factor β |
TNF |
tumor necrosis factor |
TNFR |
tumor necrosis factor receptor |
VEGF |
vascular endothelial growth factor |
vIL |
viral interleukin |
WT |
wild type |
ZRE |
ZEBRA response elements |